Latest Trials

EudraCT Number: 2004-004231-53 Sponsor Protocol Number: 506067 Start Date: 2004-12-22
Sponsor Name: Royal Devon and Exeter NHS Foundation Trust
Full Title: The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke
Medical condition: Stroke
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2004-003829-28 Sponsor Protocol Number: TAK-013/EC204 Start Date: 2004-12-22
Sponsor Name: Takeda Europe R&D Centre Ltd
Full Title: An open-label investigation into the tolerability and pharmacokinetic / pharmacodynamic effects of sufugolix (TAK-013), at a dosage of 100mg twice-daily, during six months treatment of pre-menopaus...
Medical condition: symptomatic endometriosis
Disease: Version SOC Term Classification Code Term Level
7 10014778 LLT
Population Age: Adults Gender: Female
Trial protocol: GB (Completed) DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-002070-36 Sponsor Protocol Number: GLU-005 Start Date: 2004-12-22
Sponsor Name: Metcon Medicin AB
Full Title: Efficacy of MM005-Granulae as prophylaxis for nocturnal hypoglycemia in insulin treated Type 1 diabetic subjects. A double-blind, randomized, placebo-controlled phase II multi-center study in three...
Medical condition: Diabetes type I
Disease: Version SOC Term Classification Code Term Level
6,1 10045228 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-001339-41 Sponsor Protocol Number: N01175 Start Date: 2004-12-22
Sponsor Name: UCB S.A. Pharma Sector
Full Title: A therapeutic confirmatory, open-label, multi-center, randomized 2 parallel groups, community-based trial studying the efficacy and safety of levetiracetam (1000 to 3000 mg/day oral tablets 250-50...
Medical condition: Monotherapy in subjects with newly diagnosed epilepsy
Disease: Version SOC Term Classification Code Term Level
7.0 10015037 LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) FI (Completed) SE (Completed) SK (Completed) IE (Completed) CZ (Completed) GB (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed) HU (Completed) PT (Not Authorised) DK (Completed)
Trial results: View results
EudraCT Number: 2004-002598-21 Sponsor Protocol Number: SP826 Start Date: 2004-12-22
Sponsor Name: Schwarz Biosciences GmbH
Full Title: A phase 3b, open-label, multicenter, multinational trial to evaluate the effects of rotigotine transdermal patch on early morning motor impairment and sleep disorders in patients with idiopathic Pa...
Medical condition: Parkinson's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-000711-26 Sponsor Protocol Number: IOM-114 Start Date: 2004-12-22
Sponsor Name: Bracco Imaging S.p.A.
Full Title: ABDOMINAL COMPUTED TOMOGRAPHY: IOMERON®400 VS VISIPAQUE™320 ENHANCEMENT (ACTIVE).
Medical condition: subjects with mild to moderate renal impairment scheduled to undergo clinically-indicated IV contrast –enhanced MDCT scanning of the liver
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) SE (Prematurely Ended) GB (Prematurely Ended) IT (Completed)
Trial results: View results
EudraCT Number: 2004-002362-37 Sponsor Protocol Number: GlaxoSmithKline, B2C101762 Start Date: 2004-12-22
Sponsor Name: GlaxoSmithKline Research & Development Limited
Full Title: A multicentre, randomised, double-blind, placebo-controlled, dose ascending, four way crossover study to examine efficacy (FEV1),safety, tolerability, pharmacodynamics and pharmacokinetics of sing...
Medical condition: GW642444 is a new potent and selective inhaled beta-2-receptor agonist, which is being developed for once daily treatment of asthma and COPD.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results
EudraCT Number: 2004-004230-14 Sponsor Protocol Number: Clin-AGI001-002 Start Date: 2004-12-22
Sponsor Name: AGI Therapeutics Limited
Full Title: A randomised, double-blind, placebo-controlled study of AGI 001 in the treatment of irritable bowel syndrome.
Medical condition: Irritable Bowel Syndrome
Disease: Version SOC Term Classification Code Term Level
6.0 10023003 PT
Population Age: Gender: Male, Female
Trial protocol: IE (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000712-42 Sponsor Protocol Number: IOM-115 Start Date: 2004-12-22
Sponsor Name: Bracco Imaging S.p.A.
Full Title: Enhacement of the lower extremities computed tomography: IOMERON®-400 VS VISIPAQUE™-320 (ELECTIV).
Medical condition: subjects with mild to moderate renal impairment (SCr =1.5-2.5 mg/dL and/or calculated CrCl = 10-60 mL/min) who undergo clinically-indicated IV contrast-enhanced MDCTA scanning of the lower extremit...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) SE (Completed) GB (Prematurely Ended) IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-003847-37 Sponsor Protocol Number: REM 04 15 Start Date: 2004-12-21
Sponsor Name: BIOPROJET
Full Title: An Open label uncontrolled study of the safety and efficacy of chronic intravenous Remodulin in patients with pulmonary Arterial Hypertension
Medical condition: Pulmonary Arterial Hypertension
Disease: Version SOC Term Classification Code Term Level
6.1 10037400 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe